<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>53</viewCount><searchCount>0</searchCount></scores><additional><omics_type>Unknown</omics_type><volume>7(1)</volume><submitter>Alam U</submitter><pubmed_abstract>Vitamin D deficiency is now recognized as a condition of increasing prevalence worldwide. Vitamin D has an established role in calcium and bone metabolism; however, more recently associations with vitamin D deficiency and risk of developing diabetes, diabetes complications, and cardiovascular disease have all been acknowledged. The vitamin D receptor is ubiquitously expressed, and experimental, in vitro, and in vivo studies strongly suggest a role in regulating the transcription of multiple genes beyond calcium homeostasis. These include antiproliferative, immunomodulatory, angiogenic, inhibition of the renin-angiotensin-aldosterone system, and neurotrophic factor expression. Observational studies report a strong association between vitamin D deficiency and cardiovascular and metabolic disorders; however, there remains a paucity of large long-term randomized clinical trials showing a benefit with treatment. An increasing body of literature suggests a possible pathogenetic role of vitamin D in the long-term complications of diabetes and vitamin D deficiency may also exacerbate symptoms of painful diabetic peripheral neuropathy. It remains unknown if supplementation of vitamin D to normal or non-deficient levels alters pathogenetic processes related to diabetic microvascular complications. With the high prevalence of vitamin D deficiency in patients with diabetes and putative mechanisms linking vitamin D deficiency to diabetic complications, there is a compelling argument for undertaking large well-designed randomized controlled trials of vitamin D supplementation.</pubmed_abstract><journal>Diabetes therapy : research, treatment and education of diabetes and related disorders</journal><pagination>11-26</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4801816</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Vitamin D and Diabetic Complications: True or False Prophet?</pubmed_title><pmcid>PMC4801816</pmcid><pubmed_authors>Javed S</pubmed_authors><pubmed_authors>Alam U</pubmed_authors><pubmed_authors>Arul-Devah V</pubmed_authors><pubmed_authors>Malik RA</pubmed_authors><view_count>53</view_count></additional><is_claimable>false</is_claimable><name>Vitamin D and Diabetic Complications: True or False Prophet?</name><description>Vitamin D deficiency is now recognized as a condition of increasing prevalence worldwide. Vitamin D has an established role in calcium and bone metabolism; however, more recently associations with vitamin D deficiency and risk of developing diabetes, diabetes complications, and cardiovascular disease have all been acknowledged. The vitamin D receptor is ubiquitously expressed, and experimental, in vitro, and in vivo studies strongly suggest a role in regulating the transcription of multiple genes beyond calcium homeostasis. These include antiproliferative, immunomodulatory, angiogenic, inhibition of the renin-angiotensin-aldosterone system, and neurotrophic factor expression. Observational studies report a strong association between vitamin D deficiency and cardiovascular and metabolic disorders; however, there remains a paucity of large long-term randomized clinical trials showing a benefit with treatment. An increasing body of literature suggests a possible pathogenetic role of vitamin D in the long-term complications of diabetes and vitamin D deficiency may also exacerbate symptoms of painful diabetic peripheral neuropathy. It remains unknown if supplementation of vitamin D to normal or non-deficient levels alters pathogenetic processes related to diabetic microvascular complications. With the high prevalence of vitamin D deficiency in patients with diabetes and putative mechanisms linking vitamin D deficiency to diabetic complications, there is a compelling argument for undertaking large well-designed randomized controlled trials of vitamin D supplementation.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Mar</publication><modification>2022-02-09T15:02:04.587Z</modification><creation>2019-03-27T03:09:59Z</creation></dates><accession>S-EPMC4801816</accession><cross_references><pubmed>26971351</pubmed><doi>10.1007/s13300-016-0159-x</doi></cross_references></HashMap>